Introduction
Accurate staging of lung cancer is critical for determining prognosis and selecting appropriate treatment strategies. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become the gold standard for sampling mediastinal and hilar lymph nodes. However, conventional B-mode ultrasound imaging often lacks the specificity required to distinguish between benign reactive nodes and malignant involvement. To address this, clinicians have integrated two auxiliary real-time techniques: Endobronchial Ultrasound (EBUS) elastography and Rapid Onsite Cytological Evaluation (ROSE).
While both tools are used individually to improve biopsy yields, their combined diagnostic value has not been extensively quantified. This study investigates whether a dual-modality approach can provide a more reliable diagnostic framework for clinicians during the procedure.
Methodology
Researchers conducted a retrospective chart review of 247 patients (comprising 345 lymph nodes) who underwent EBUS-TBNA at Zhongda Hospital, Southeast University, between December 2018 and September 2020.
Diagnostic Tools and Scoring
- EBUS Elastography: This technique measures tissue stiffness, represented by a color-coded map. Because malignant tumors are generally stiffer than healthy tissue, "harder" nodes are considered more suspicious. Nodes were classified into three types:
- Type 1: Predominantly non-blue (soft).
- Type 2: Partially blue and partially non-blue.
- Type 3: Predominantly blue (hard).
- ROSE: Immediate microscopic evaluation of the aspirated sample was performed to assess adequacy and provide a preliminary diagnosis. Results were categorized into five groups following the Papanicolaou Society guidelines, ranging from non-diagnostic to positive for malignancy.
Statistical Analysis
The diagnostic performance of elastography alone, ROSE alone, and the combination of both was evaluated using Receiver Operating Characteristic (ROC) curves. The final pathological diagnosis served as the "ground truth" reference standard.
Results
Of the 345 lymph nodes examined, 148 were confirmed as malignant (primarily adenocarcinoma, small cell carcinoma, and squamous cell carcinoma), while 99 were benign (including sarcoidosis and inflammatory conditions). The study revealed that while individual modalities are useful, their combination offers superior diagnostic accuracy, particularly in terms of specificity.
| Diagnostic Method | Sensitivity | Specificity | AUC |
|---|---|---|---|
| EBUS Elastography Alone | 90.51% | 57.26% | - |
| ROSE Alone | 96.32% | 79.05% | - |
| Combined (Elastography + ROSE) | 86.61% | 92.65% | 0.942 |
For the combined group, the positive likelihood ratio (PLR) was 11.78 and the negative likelihood ratio (NLR) was 0.14. The most significant finding was the dramatic improvement in specificity when combining the tools—increasing from 57.26% (elastography alone) to 92.65% (combined). This indicates that the dual-modality approach is highly effective at reducing false-positive results.
Discussion
The findings suggest that EBUS elastography and ROSE serve complementary roles. Elastography acts as an effective "scouting" tool, helping the bronchoscopist identify the stiffest, most suspicious areas of a lymph node for targeted sampling. ROSE then provides immediate biological confirmation of the sample's nature, ensuring that the material collected is adequate for a definitive diagnosis.
The specificity boost is critical because elastography can be subjective and influenced by external factors like a patient’s heart rate or breathing patterns. ROSE acts as a necessary biological "sanity check" for the mechanical data provided by the ultrasound. This real-time synergy allows for more confident clinical decisions, potentially reducing the need for repeat procedures or more invasive surgical staging like mediastinoscopy.
Limitations
As a retrospective, single-center study, the findings may be influenced by specific institutional practices and equipment. Future multi-center prospective trials with larger cohorts are necessary to generalize these results. Additionally, future research could integrate other ultrasound features—such as node size, shape, and vascularity—to create a more comprehensive diagnostic algorithm.
Conclusion
The combination of EBUS elastography and ROSE significantly increases the diagnostic value of EBUS-TBNA in evaluating mediastinal and hilar lymph nodes. This approach provides a highly specific and accurate method for lung cancer staging, facilitating more precise and immediate clinical management.
Summary updated